#header #header-bottom .menu-wrapper{display: block!important;}

Attention javascript est désactivé sur votre poste.
Ce site nécessite l'activation de javascript pour fonctionner correctement.

Pharmaco-imaging study of the effects of Debio1143, a new orally available IAP inhibitor, in a triple-negative breast cancer model

Home . Resources . Pharmaco-imaging study of the effects of Debio1143, a new orally available IAP inhibitor, in a triple-negative breast cancer model

20 rue Jean Mazen - FR - 21000 Dijon
Tel.+33 380 788 260

Receive our general news!